U.S. markets closed

aTyr Pharma, Inc. (LIFE)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
Visitors trend2W10W9M
4.7500-0.0200 (-0.42%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Slow Stochastic

Slow Stochastic

Performance Outlook
Previous Close4.7700
Open4.8500
Bid4.7200 x 900
Ask4.8500 x 800
Day's Range4.6800 - 4.9400
52 Week Range2.9300 - 8.3300
Volume265,729
Avg. Volume925,915
Market Cap76.307M
Beta (5Y Monthly)2.05
PE Ratio (TTM)N/A
EPS (TTM)-2.2920
Earnings DateAug 11, 2021 - Aug 16, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est16.00
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • aTyr Pharma Presents Poster Demonstrating Functional Selectivity of Second Anti-NRP2 Antibody
    GlobeNewswire

    aTyr Pharma Presents Poster Demonstrating Functional Selectivity of Second Anti-NRP2 Antibody

    Preclinical candidate is second to demonstrate selective blocking ability from in-house panel of antibodies targeting NRP2. aNRP2-14 blocks Semaphorin 3F/NRP2 signaling pathways which are implicated in immune-mediated diseases. SAN DIEGO, June 10, 2021 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel biological pathways, today announced the presentation of a poster at the Antibody Engin

  • ACCESSWIRE

    Love Hemp Group PLC Announces Issue of Warrants and Issue of Equity

    LONDON, ENGLAND / ACCESSWIRE / June 9, 2021 / Love Hemp Group PLC (AQSE:LIFE)(OTCQB:WRHLF), one of the UK's leading CBD and Hemp product suppliers, announces the issue of warrants and equity by the Company.Issue of warrantsThe Company has issued 15,746,325 warrants with an exercise price of 3.

  • Have Insiders Been Buying aTyr Pharma, Inc. (NASDAQ:LIFE) Shares?
    Simply Wall St.

    Have Insiders Been Buying aTyr Pharma, Inc. (NASDAQ:LIFE) Shares?

    We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly. The...